Patrick A. Kupelian

18.8k total citations · 2 hit papers
342 papers, 13.8k citations indexed

About

Patrick A. Kupelian is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patrick A. Kupelian has authored 342 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 254 papers in Pulmonary and Respiratory Medicine, 213 papers in Radiation and 102 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patrick A. Kupelian's work include Advanced Radiotherapy Techniques (212 papers), Prostate Cancer Diagnosis and Treatment (165 papers) and Prostate Cancer Treatment and Research (140 papers). Patrick A. Kupelian is often cited by papers focused on Advanced Radiotherapy Techniques (212 papers), Prostate Cancer Diagnosis and Treatment (165 papers) and Prostate Cancer Treatment and Research (140 papers). Patrick A. Kupelian collaborates with scholars based in United States, Canada and Netherlands. Patrick A. Kupelian's co-authors include Eric A. Klein, Twyla R. Willoughby, C.A. Reddy, Sanford L. Meeks, K Langen, Craig D. Zippe, Arul Mahadevan, Howard S. Levin, Thomas H. Wagner and Michael J. Zeléfsky and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Patrick A. Kupelian

334 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials

2013 334 citations Christopher R. King, Donald B. Fuller et al. profile →
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study

2017 226 citations Pin‐Chieh Wang, Michael L. Steinberg et al. profile →

Peers

Countries citing papers authored by Patrick A. Kupelian

Since Specialization

Citations

This map shows the geographic impact of Patrick A. Kupelian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Kupelian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Kupelian more than expected).

Fields of papers citing papers by Patrick A. Kupelian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick A. Kupelian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Kupelian. The network helps show where Patrick A. Kupelian may publish in the future.

Co-authorship network of co-authors of Patrick A. Kupelian

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick A. Kupelian. A scholar is included among the top collaborators of Patrick A. Kupelian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick A. Kupelian. Patrick A. Kupelian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bilateral breast treatment in a single arc using RapidArc Dynamic: A planning comparison with conventional volumetric modulated arc therapy 2025 ·Journal of Applied Clinical Medical Physics ·(unknown), Luca Cozzi, (unknown), (unknown), (unknown), (unknown), Yun Yang, Boon‐Keng Teo, (unknown), Harish Kalra, Francisco J. Reynoso, Patrick A. Kupelian, Sushil Beriwal	0
2	Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients 2021 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Naomi Jiang, Donald B. Fuller, Andrew Loblaw, (unknown), Alan J. Katz, Sean P. Collins, Nima Aghdam, Simeng Suy, Kevin L. Stephans, Ye Yuan, Nicholas G. Nickols, Vedang Murthy, (unknown), Patrick A. Kupelian, Michael L. Steinberg, Tahmineh Romero, Amar U. Kishan	40
3	Hypofractionation and prostate cancer: A good option for Africa? 2017 ·SHILAP Revista de lepidopterología ·Luca Incrocci, Ben Heijmen, Patrick A. Kupelian, Hannah Simonds	5
4	Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Skyler B. Johnson, Pamela R. Soulos, Timothy D. Shafman, C.A. Mantz, (unknown), (unknown), (unknown), Sean P. Collins, Simeng Suy, Jeffrey V. Brower, M.A. Ritter, Christopher King, Patrick A. Kupelian, Eric M. Horwitz, Alan Pollack, Matthew C. Abramowitz, M.A. Hallman, Sergio Faria, Cary P. Gross, James B. Yu	1
5	Younger Age but Not Receptor Status May Predispose to Radiation Necrosis in Radiation Therapy for Breast Cancer Brain Metastasis 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Rebecca Levin-Epstein, (unknown), Stephen Tenn, Michael T. Selch, Antônio De Salles, Nader Pouratian, Susan A. McCloskey, Patrick A. Kupelian, Isaac Yang, (unknown), Tania Kaprealian	1
6	SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer 2015 ·Practical Radiation Oncology ·Amar U. Kishan, Pin‐Chieh Wang, Shrinivasa K. Upadhyaya, Henrik Hauswald, D. Jeffrey Demanes, Nicholas G. Nickols, Mitchell Kamrava, Ahmad Sadeghi, Patrick A. Kupelian, Michael L. Steinberg, Nicolas D. Prionas, Mark K. Buyyounouski, Christopher R. King	21
7	Helical Tomotherapy: Image-Guided and Adaptive Radiotherapy 2011 ·Frontiers of radiation therapy and oncology ·Patrick A. Kupelian, K Langen	14
8	Dosimetric evaluation of a novel polymer gel dosimeter for proton therapy 2010 ·Medical Physics ·O. Zeidan, (unknown), O. Lopatiuk‐Tirpak, Patrick A. Kupelian, Sanford L. Meeks, W. C. Hsi, Zeyuan Li, Jatinder Palta, M Maryanski	54
9	A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer 2009 ·International Journal of Radiation OncologyBiologyPhysics ·M.A. Ritter, Jeffrey D. Forman, Patrick A. Kupelian, Daniel G. Petereit, C.A. Lawton, Richard J. Chappell, Wolfgang A. Tomé	8
10	Dosimetric effects of rotational output variation and x‐ray target degradation on helical tomotherapy plans 2009 ·Medical Physics ·R Staton, K Langen, Patrick A. Kupelian, Sanford L. Meeks	17
11	Real-Time Simulation of 4D Lung Tumor Radiotherapy Using a Breathing Model 2008 ·Lecture notes in computer science ·Anand P. Santhanam, Twyla R. Willoughby, Amish P. Shah, Sanford L. Meeks, Jannick P. Rolland, Patrick A. Kupelian	11
12	Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Twyla R. Willoughby, C.A. Reddy, Eric A. Klein, Arul Mahadevan	291
13	Evaluation of Image-Guidance Strategies in the Treatment of Localized Prostate Cancer 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Choonik Lee, K Langen, O. Zeidan, R. Mañon, Twyla R. Willoughby, Sanford L. Meeks	96
14	Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, (unknown), Deepak Khuntia, C.A. Reddy, Eric A. Klein, Arul Mahadevan	158
15	Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy 2005 ·Prostate Cancer and Prostatic Diseases ·Sean Cavanaugh, Clifton D. Fuller, Patrick A. Kupelian, C.A. Reddy, Patrick T. Bradshaw, Bradley H Pollock, M. Fuß	11
16	Defining sexual outcomes after treatment for localized prostate carcinoma 2002 ·Cancer ·Leslie R. Schover, Rachel T. Fouladi, Carla L. Warneke, Leah Neese, Eric A. Klein, Craig D. Zippe, Patrick A. Kupelian	233
17	Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostate 2000 ·Urology ·Janice A. Lyons, Patrick A. Kupelian, Dasarahally S. Mohan, C.A. Reddy, Eric A. Klein	110
18	Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. 1997 ·Journal of Clinical Oncology ·Patrick A. Kupelian, Varant Kupelian, John S. Witte, Roger M. Macklis, Eric A. Klein	71
19	Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery 1997 ·Radiation Oncology Investigations ·(unknown), John H. Suh, Patrick A. Kupelian, Jason W. Sohn, Gene H. Barnett	31
20	Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone 1996 ·International Journal of Radiation OncologyBiologyPhysics ·Patrick A. Kupelian, Ritsuko Komaki, Pamela Allen	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact